首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1800248

全球氣道支架市場：2025 年至 2030 年預測

Global Airway Stent Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月12日 | 出版商:

Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計氣道支架市場將從 2025 年的 141,017,000 美元成長到 2030 年的 181,331,000 美元，複合年成長率為 5.16%。

由於慢性呼吸系統疾病的盛行率不斷上升以及微創手術的日益普及，預計氣道支架市場將在2025年至2030年間大幅成長。氣道支架用於透過機械清創、雷射消融、動態療法和支氣管內近距離放射治療等手術來治療中央氣道的良性和惡性病變，並且是治療肺癌、結核病和慢性阻塞性肺病(COPD) 等疾病的關鍵。生物分解性支架和藥物釋放型支架的進步、污染水平的上升以及吸煙率的居高不下推動了氣道支架市場的發展。北美引領市場，而亞太地區則顯示出巨大的成長潛力。挑戰包括與支架置入相關的併發症。

市場促進因素

呼吸系統疾病盛行率上升

肺癌、結核病和慢性阻塞性肺病 (COPD) 等慢性呼吸系統疾病發生率的不斷上升是氣道支架市場的主要驅動力。全球污染水平的上升和持續的高吸煙率加劇了這些疾病的負擔。氣道支架對於維持阻塞性病變患者的氣道通暢性以及支持性治療和安寧療護至關重要。對有效干預措施來管理這些疾病的需求日益成長，這推動了對先進支架技術的需求。

偏好微創治療

與傳統手術相比，微創手術恢復時間更快、併發症風險更低，因此人們日益偏好微創手術，推動了氣道支架的普及。內視鏡支架置入等治療技術能精準治療氣道阻塞，改善患者預後。這一趨勢在醫院和門診手術中心尤為明顯，微創手術擴大被納入標準治療通訊協定，進一步推動了市場成長。

支架技術的進步

生物分解性和藥物釋放型氣道支架的技術創新正在推動市場成長。生物分解性支架無需移除手術，並可減少長期併發症；而藥物釋放型支架則提供標靶治療，可預防血管再阻塞和發炎。這些進步正在改善患者安全性和治療效果，促進臨床應用，並支持市場擴張。

市場限制

氣道支架市場面臨挑戰，因為支架置入相關併發症（例如移位、感染和肉芽組織形成）可能會阻礙其推廣應用並增加醫療成本。先進支架的高昂成本以及對熟練專業人員進行內視鏡手術的需求也構成了障礙，尤其是在醫療基礎設施有限的發展中地區。透過改進支架設計和培訓專案來應對這些挑戰，對於市場的持續成長至關重要。

介紹
北美洲
- 美國
- 加拿大
- 墨西哥
南美洲
- 巴西
- 阿根廷
- 其他
歐洲
- 英國
- 德國
- 法國
- 西班牙
- 其他
中東和非洲
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 其他
亞太地區
- 日本
- 中國
- 印度
- 韓國
- 印尼
- 泰國
- 其他

第8章競爭格局及分析

主要企業和策略分析
市場佔有率分析
合併、收購、協議和合作
競爭對手儀表板

第9章：公司簡介

Boston Scientific Corporation
Novatech SA
Cook Medical
MICRO-TECH Europe GmbH
Medtronic
Cook Medical
MICRO-TECH（Nanjing）Co., Ltd.
Merit Medical Systems

第10章調查方法

簡介目錄

Product Code: KSI061612095

The global airway stent market is expected to grow from USD 141.017 million in 2025 to USD 181.331 million in 2030, at a CAGR of 5.16%.

The global airway stent market is projected to experience significant growth from 2025 to 2030, driven by the rising prevalence of respiratory chronic disorders and the increasing adoption of minimally invasive procedures. Airway stents, used to manage benign and malignant lesions in the central airway through techniques like mechanical debridement, laser resection, photodynamic therapy, and endobronchial brachytherapy, are critical for treating conditions such as lung cancer, tuberculosis, and chronic obstructive pulmonary disease (COPD). The market is propelled by advancements in biodegradable and drug-eluting stents, rising pollution levels, and high tobacco smoking rates. North America leads the market, while Asia-Pacific shows strong growth potential. Challenges include complications associated with stent implantation.

Market Drivers

Rising Prevalence of Respiratory Disorders

The increasing incidence of chronic respiratory conditions, including lung cancer, tuberculosis, and COPD, is a primary driver of the airway stent market. Rising pollution levels and the persistent high prevalence of tobacco smoking globally contribute to the growing burden of these diseases. Airway stents are essential for maintaining airway patency in patients with obstructive lesions, supporting both therapeutic and palliative care. The escalating need for effective interventions to manage these conditions is driving demand for advanced stent technologies.

Preference for Minimally Invasive Procedures

The growing preference for minimally invasive procedures, which offer reduced recovery times and lower complication risks compared to traditional surgeries, is boosting the adoption of airway stents. Techniques like endoscopic stent placement enable precise treatment of airway obstructions, improving patient outcomes. This trend is particularly prominent in hospitals and ambulatory surgical centers, where minimally invasive approaches are increasingly integrated into standard care protocols, further fueling market growth.

Advancements in Stent Technology

Innovations in biodegradable and drug-eluting airway stents are enhancing market growth. Biodegradable stents eliminate the need for removal procedures, reducing long-term complications, while drug-eluting stents deliver targeted therapies to prevent restenosis and inflammation. These advancements improve patient safety and treatment efficacy, driving adoption across clinical settings and supporting the market's expansion.

Market Restraints

The airway stent market faces challenges due to complications associated with stent implantation, such as migration, infection, or granulation tissue formation, which can deter adoption and increase healthcare costs. The high cost of advanced stents and the need for skilled professionals to perform endoscopic procedures also pose barriers, particularly in developing regions with limited healthcare infrastructure. Addressing these challenges through improved stent designs and training programs will be critical for sustained market growth.

Market Segmentation

By Material Type

The market is segmented into metal, silicone, and hybrid stents. Silicone stents dominate due to their flexibility and biocompatibility, making them suitable for long-term use in benign conditions. Metal stents are preferred for malignant obstructions due to their durability, while hybrid stents, combining metal and silicone properties, are gaining traction for their versatility in complex cases.

By End-User

The market is divided into hospitals and clinics, and ambulatory surgical centers. Hospitals and clinics hold the largest share, driven by their advanced infrastructure and high volume of respiratory procedures. Ambulatory surgical centers are a growing segment, supported by the increasing adoption of minimally invasive techniques in outpatient settings.

By Geography

The market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. North America leads due to its advanced healthcare systems, high prevalence of respiratory disorders, and early adoption of innovative stent technologies. Asia-Pacific is expected to grow rapidly, driven by increasing healthcare investments, rising pollution levels, and growing awareness of respiratory health in countries like China and India. Europe, South America, and the Middle East and Africa are emerging markets, supported by improving healthcare infrastructure.

The airway stent market is set for robust growth from 2025 to 2030, driven by the rising prevalence of respiratory disorders, preference for minimally invasive procedures, and advancements in biodegradable and drug-eluting stents. Despite challenges from implantation complications and high costs, the market's outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on innovative stent designs, cost-effective solutions, and clinician training to capitalize on the growing demand for airway stents in managing chronic respiratory conditions.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Different segments covered under the global airway stent market report are as below:

By Material Type

Metal
Silicone
Hybrid

By End-User

Hospitals and Clinics
Ambulatory Surgical Centers

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL AIRWAY STENT MARKET BY MATERIAL TYPE

5.1. Introduction
5.2. Metal
5.3. Silicone
5.4. Hybrid

6. GLOBAL AIRWAY STENT MARKET BY END-USER

6.1. Introduction
6.2. Hospitals and Clinics
6.3. Ambulatory Surgical Centers

7. GLOBAL AIRWAY STENT MARKET BY GEOGRAPHY

7.1. Introduction
7.2. North America
- 7.2.1. USA
- 7.2.2. Canada
- 7.2.3. Mexico
7.3. South America
- 7.3.1. Brazil
- 7.3.2. Argentina
- 7.3.3. Others
7.4. Europe
- 7.4.1. United Kingdom
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Others
7.5. Middle East & Africa
- 7.5.1. Saudi Arabia
- 7.5.2. UAE
- 7.5.3. Israel
- 7.5.4. Others
7.6. Asia Pacific
- 7.6.1. Japan
- 7.6.2. China
- 7.6.3. India
- 7.6.4. South Korea
- 7.6.5. Indonesia
- 7.6.6. Thailand
- 7.6.7. Others